Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Dr. Govindan on Lung Cancer: Past, Present, and Future Directions
Dr West
My friend and colleague, Dr. Ramiswamy Govindan, is one of the national leaders in lung cancer, and he was kind enough to participate in our NSCLC Patient Education Forum. There, he spoke in some general terms about what patients might expect from chemo/radiation for locally advanced lung cancer (which could include limited SCLC as well as stage III NSCLC), but he also used the occasion to talk about general guidelines about where we've come from and where we're going with cancer treatments. He also covered his impressions on diet, supplements, managing toxicities, and other practical aspects of receiving cancer treatment.
Here is the link to the audio and video versions of the podcast, as well as the figures and transcript.
[powerpress]
govindan lung ca past present future audio podcast
govindan-lung-ca-past-present-future-figures
govindan-lung-ca-past-present-future-transcript
I hope you find it interesting and helpful. We'll be posting the last few podcasts of presentations from the NSCLC Patient Education in the next few weeks, on the topic of advanced NSCLC.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Article
Imagine your body's defense system, the lymphatic system, suddenly turning against you. This is the reality for those facing lymphoma, a cancer of the immune system's crucial network. This article delves into the complexities of lymphoma, exploring its various forms, from the aggressive to the indolent, and examining the latest breakthroughs in treatment, including the groundbreaking POLARIX trial and cutting-edge therapies for relapsed cases. Whether you're a patient, a loved one, or simply curious about this complex disease, this comprehensive overview will provide valuable insights into the current state of lymphoma care and the promising future of research.
Image
Article
Registration is now open!
Join us for the annual 2024 Blood Cancers OncTalk!
Register Now!
Image
Video
Drs. Meredith McKean, Dr. Doug Micalizzi and patient advocate and lung cancer survivor, Ivy Elkins, discuss the importance of early detection and treatment across cancer types, including skin, lung, and breast.
To watch the complete playlist click here.
Online Community
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Recent Comments
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: